{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:14:59Z","timestamp":1786324499146,"version":"build-2736575974"},"reference-count":23,"publisher":"Georg Thieme Verlag KG","issue":"09","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Neuropsiquiatr"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Medication-overuse headache affects 1 to 2% of the global population and is often associated with chronic migraine. This condition significantly impacts the lives of patients, as well as their families, and it poses a major economic burden due to lost productivity and medical costs. The present narrative review is part of a controversy session. We argue that reversing the behavior of overusing symptomatic pain medications is important for the treatment of this type of headache. To support this argument, the article reviews and critically analyzes the relevant literature on the subject.<\/jats:p>","DOI":"10.1055\/s-0045-1809332","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T22:49:03Z","timestamp":1753742943000},"page":"001-004","source":"Crossref","is-referenced-by-count":3,"title":["Calcitonin gene-related peptide monoclonal antibodies and medication-overuse headache: stopping excessive pain medication is still necessary"],"prefix":"10.1055","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5725-2637","authenticated-orcid":false,"given":"Pedro Augusto Sampaio","family":"Rocha-Filho","sequence":"additional","affiliation":[{"name":"Universidade Federal de Pernambuco, Centro de Ci\u00eancias M\u00e9dicas, \u00c1rea Acad\u00eamica de Neuropsiquiatria, Recife PE, Brazil."},{"name":"Universidade de Pernambuco, Hospital Universit\u00e1rio Oswaldo Cruz, Servi\u00e7o de Neurologia, Recife PE, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-022-00415-0","article-title":"Medication overuse headache","volume":"9","author":"S Ashina","year":"2023","journal-title":"Nat Rev Dis Primers"},{"issue":"01","key":"ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition","volume":"38","author":"Headache Classification Committee of the International Headache Society","year":"2018","journal-title":"Cephalalgia"},{"issue":"09","key":"ref3","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S1474-4422(19)30146-2","article-title":"Pathophysiology, prevention, and treatment of medication overuse headache","volume":"18","author":"H C Diener","year":"2019","journal-title":"Lancet Neurol"},{"issue":"03","key":"ref4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/head.13459","article-title":"Migraine Progression: A Systematic Review","volume":"59","author":"D C Buse","year":"2019","journal-title":"Headache"},{"issue":"07","key":"ref5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1590\/0004-282x20190078","article-title":"Consensus of the Brazilian Headache Society on the treatment of chronic migraine","volume":"77","author":"F Kowacs","year":"2019","journal-title":"Arq Neuropsiquiatr"},{"issue":"04","key":"ref6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1177\/0333102415593088","article-title":"Treatment of medication-overuse headache: A systematic review","volume":"36","author":"C C Chiang","year":"2016","journal-title":"Cephalalgia"},{"issue":"05","key":"ref7","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s13760-021-01758-3","article-title":"FRAMES protocol versus simple advice for medication-overuse headache: a prospective, randomized, controlled clinical trial","volume":"121","author":"A LM Alves","year":"2021","journal-title":"Acta Neurol Belg"},{"issue":"03","key":"ref8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1468-1331.2010.03157.x","article-title":"Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache","volume":"18","author":"P Rossi","year":"2011","journal-title":"Eur J Neurol"},{"issue":"06","key":"ref9","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1177\/0333102413515338","article-title":"Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project)","volume":"34","author":"L Bendtsen","year":"2014","journal-title":"Cephalalgia"},{"issue":"09","key":"ref10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1177\/0333102414521508","article-title":"A consensus protocol for the management of medication-overuse headache: Evaluation in a multicentric, multinational study","volume":"34","author":"C Tassorelli","year":"2014","journal-title":"Cephalalgia"},{"issue":"02","key":"ref11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/0333102417737779","article-title":"Complete detoxification is the most effective treatment of medication-overuse headache: A randomized controlled open-label trial","volume":"38","author":"L N Carlsen","year":"2018","journal-title":"Cephalalgia"},{"issue":"14","key":"ref12","doi-asserted-by":"publisher","first-page":"e1409","DOI":"10.1212\/WNL.0000000000200117","article-title":"Patient-centered treatment of chronic migraine with medication overuse: a prospective, randomized, pragmatic clinical trial","volume":"98","author":"T J Schwedt","year":"2022","journal-title":"Neurology"},{"issue":"09","key":"ref13","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1001\/jamaneurol.2020.1179","article-title":"Comparison of 3 treatment strategies for medication overuse headache: a randomized clinical trial","volume":"77","author":"L N Carlsen","year":"2020","journal-title":"JAMA Neurol"},{"issue":"01","key":"ref14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/head.14036","article-title":"Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2","volume":"61","author":"H C Diener","year":"2021","journal-title":"Headache"},{"issue":"03","key":"ref15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/0333102420966658","article-title":"Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine","volume":"41","author":"D W Dodick","year":"2021","journal-title":"Cephalalgia"},{"issue":"01","key":"ref16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s10194-020-01173-8","article-title":"The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study","volume":"21","author":"S D Silberstein","year":"2020","journal-title":"J Headache Pain"},{"issue":"20","key":"ref17","doi-asserted-by":"publisher","first-page":"e2309","DOI":"10.1212\/WNL.0000000000007497","article-title":"Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial","volume":"92","author":"S J Tepper","year":"2019","journal-title":"Neurology"},{"issue":"07","key":"ref18","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/j.1468-2982.2007.01326.x","article-title":"Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study","volume":"27","author":"H C Diener","year":"2007","journal-title":"Cephalalgia"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jns.2013.05.003","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline","volume":"331","author":"S D Silberstein","year":"2013","journal-title":"J Neurol Sci"},{"issue":"08","key":"ref20","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.euroneuro.2014.03.010","article-title":"Sodium valproate in migraine without aura and medication overuse headache: a randomized controlled trial","volume":"24","author":"P Sarchielli","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"issue":"02","key":"ref21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1526-4610.2006.00684.x","article-title":"Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial","volume":"47","author":"S D Silberstein","year":"2007","journal-title":"Headache"},{"issue":"12","key":"ref22","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1055\/s-0043-1777723","article-title":"The history and rationale of the development of new drugs for migraine treatment","volume":"81","author":"P A Kowacs","year":"2023","journal-title":"Arq Neuropsiquiatr"},{"issue":"09","key":"ref23","doi-asserted-by":"publisher","first-page":"3331024241269735","DOI":"10.1177\/03331024241269735","article-title":"International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine","volume":"44","author":"F Puledda","year":"2024","journal-title":"Cephalalgia"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0045-1809332.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T22:49:03Z","timestamp":1753742943000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0045-1809332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":23,"journal-issue":{"issue":"09","published-online":{"date-parts":[[2025,6,21]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["s00451809332"],"URL":"https:\/\/doi.org\/10.1055\/s-0045-1809332","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0004-282X","1678-4227"],"issn-type":[{"value":"0004-282X","type":"print"},{"value":"1678-4227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]}}}